Skip to content

Continous Quadratus Lumborum Block for Hepatic Surgery With Right Subcostal Incision

Ultrasound-guided Continous Quadratus Lumborum Block: Effect on Acute Pain and Quality of Recovery After Hepatic Surgery With Right Subcostal Incision

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02914015
Enrollment
40
Registered
2016-09-26
Start date
2018-08-01
Completion date
2019-05-29
Last updated
2019-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia, Hepatectomy, Nerve Block

Brief summary

This prospective, randomized study, control study aims to compare the analgesic effect, opioids consumption, quality of recovery, length of hospital stay and et al. between unilateral continuous quadratus lumborum block (QLB) and intravenous patient-controlled analgesia (IPCA) alone in patients undergoing hepatectomy with right J-shape subcostal incision.

Interventions

PROCEDUREContinous QLB (quadratus lumborum block)

Inject local anesthetics in between quadratus lumborum and psoas major muscle with catheter insertion and continuous local infusion

The curved (C1-5) probe of Philip CX 50 Ultrasound Scanner is used for scan

DRUGRopivacaine

* 0.6ml/kg 0.5% ropivacaine with 1:200,000 adrenaline given immediately after the correct position of the tip of the needle has been verified. * followed with 0.2% ropivacaine infusion at a rate of 0.125ml/kg/h given through the catheter inserted in between the quadratus lumborum muscle and psoas major muscle.

Bolus: 1-2mg, lock time: 10min, 1h limitation: 5-10mg. without background infusion.

Sponsors

Cui Xulei
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-70 yrs * American Society of Anesthesiologists physical statusⅠ-Ⅲ * Undergo hepatectomy with right J-shape subcostal incision * Informed consent

Exclusion criteria

* A known allergy to the drugs being used * Coagulopathy, on anticoagulants * Analgesics intake, history of substance abuse * Participating in the investigation of another experimental agent * Inability to properly describe postoperative pain to investigators (eg, language barrier, neuropsychiatric disorder)

Design outcomes

Primary

MeasureTime frame
Cumulative morphine consumptionat 24 postoperative hours

Secondary

MeasureTime frameDescription
The pain scores determined by the numeric rating scale (NRS, 0-10)At 0, 2,4, 8, 12, 24 ,48,72 hours and 7 day after the surgery
Nausea and Vomiting scoreAt 0, 2,4, 8, 12, 24 and 48 hours after the surgery
Pruritus scoreAt 0, 2,4, 8, 12, 24 and 48 hours after the surgery
Postoperative hospital length of stayUp to 6 weeks
Time of recovery of bowl movementwithin the 7 days after surgery
Quality of recovery3 days and 7 days after surgeryuse the self-assessment 11 item QoR scale to assess the patient's recovery quality
Patient satisfaction with anesthesia48 hours after surgeryuse the Chinese version Bauer questionnaire to assess the patient satisfaction with anesthesia
Ambulation timewithin the 7 days after surgery

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026